SciELO - Scientific Electronic Library Online

 
vol.18 issue4Cholesterol crystals embolization: Case reportParaquat poisoning: report of two cases and literature review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

PANTOJA ZARZA, L.; PANIAGUA DE LA RIVA, J.; MEGIDO LAHERA, M.  and  ORTIZ DE SARACHO, J.. Primary systemic amyloidosis presenting as polymialgia  rheumatica and giant cell arteritis. An. Med. Interna (Madrid) [online]. 2001, vol.18, n.4, pp.45-49. ISSN 0212-7199.

Primary systemic amyloidosis or AL-amyloidosis is an uncommon disease characterized by the accumulation in vital organs of a fibrillar protein consisting of monoclonal light chains. It is a plasma-cell dyscrasia related to multiple myeloma where clonal plasma cells in the bone marrow produce immunoglobulins that are amyloidogenic. A monoclonal component is present in the serum or urine of 90% of patients. The presentation of most patients with AL amyloidosis is usually related to congestive heart failure, nephrotic syndrome o peripheral neuropathy, but there are unusual features suggesting giant cell arteritis (GCA) and polymyalgia rheumatic (PMR). Although in the majority of AL cases the plasma cells clone is small, the assumption is that the outcome of the disease is uniformly fatal (median survival 12-15 months) and treatment is analogous to those used in malignant proliferative disease. We describe a patient with AL amyloidosis who presented with manifestations of GCA and PMR, and we review the main characteristics of primary amyloidosis.

Keywords : Primary systemic amyloidosis; Giant cell artritis; Polymyalgia rheumatica.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License